These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 24203927)
1. Factor XIII: sticking it to platelets. Munday AD; López JA Blood; 2013 Nov; 122(19):3246-7. PubMed ID: 24203927 [No Abstract] [Full Text] [Related]
2. Clot retraction is mediated by factor XIII-dependent fibrin-αIIbβ3-myosin axis in platelet sphingomyelin-rich membrane rafts. Kasahara K; Kaneda M; Miki T; Iida K; Sekino-Suzuki N; Kawashima I; Suzuki H; Shimonaka M; Arai M; Ohno-Iwashita Y; Kojima S; Abe M; Kobayashi T; Okazaki T; Souri M; Ichinose A; Yamamoto N Blood; 2013 Nov; 122(19):3340-8. PubMed ID: 24002447 [TBL] [Abstract][Full Text] [Related]
3. Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII. Mattheij NJ; Swieringa F; Mastenbroek TG; Berny-Lang MA; May F; Baaten CC; van der Meijden PE; Henskens YM; Beckers EA; Suylen DP; Nolte MW; Hackeng TM; McCarty OJ; Heemskerk JW; Cosemans JM Haematologica; 2016 Apr; 101(4):427-36. PubMed ID: 26721892 [TBL] [Abstract][Full Text] [Related]
4. Retention of platelet fibrin stabilizing factor during the platelet release reaction and clot retraction. Joist JH; Niewiarowski S Thromb Diath Haemorrh; 1973 Jun; 29(3):679-83. PubMed ID: 4271547 [No Abstract] [Full Text] [Related]
5. Role of the fibrinogen gamma-chain sequence gamma316-322 in platelet-mediated clot retraction. Remijn JA; IJsseldijk MJ; De Groot PG J Thromb Haemost; 2003 Oct; 1(10):2245-6. PubMed ID: 14521614 [No Abstract] [Full Text] [Related]
6. Platelet-based coagulation: different populations, different functions. Heemskerk JW; Mattheij NJ; Cosemans JM J Thromb Haemost; 2013 Jan; 11(1):2-16. PubMed ID: 23106920 [TBL] [Abstract][Full Text] [Related]
7. Homozygous loss of mouse tetraspanin CD82 enhances integrin αIIbβ3 expression and clot retraction in platelets. Uchtmann K; Park ER; Bergsma A; Segula J; Edick MJ; Miranti CK Exp Cell Res; 2015 Dec; 339(2):261-9. PubMed ID: 26562164 [TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: differentiation among glycoprotein IIb/IIIa antagonists. Mousa SA; Khurana S; Forsythe MS Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1162-7. PubMed ID: 10764688 [TBL] [Abstract][Full Text] [Related]
9. Lysis of clots prepared from whole blood and plasma. Taylor FB; Carroll RC; Gerrard J; Esmon CT; Radcliffe RD Fed Proc; 1981 May; 40(7):2092-8. PubMed ID: 7194803 [No Abstract] [Full Text] [Related]
10. Binding of plasma factor XIII to thrombin-receptor activated human platelets. Nagy B; Simon Z; Bagoly Z; Muszbek L; Kappelmayer J Thromb Haemost; 2009 Jul; 102(1):83-9. PubMed ID: 19572072 [TBL] [Abstract][Full Text] [Related]
11. Fibrin-fibrin and alpha 2-antiplasmin-fibrin cross-linking by platelet factor XIII increases the resistance of platelet clots to fibrinolysis. Reed GL; Matsueda GR; Haber E Trans Assoc Am Physicians; 1991; 104():21-8. PubMed ID: 1845147 [No Abstract] [Full Text] [Related]
12. Molecular mechanisms of fibrin gel clot retraction by platelets and cultured tumor cells. Tanoue K; Katagiri Y; Suzuki H Pol J Pharmacol; 1996; 48(3):341-3. PubMed ID: 9112674 [TBL] [Abstract][Full Text] [Related]
13. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood. Jámbor C; Reul V; Schnider TW; Degiacomi P; Metzner H; Korte WC Anesth Analg; 2009 Oct; 109(4):1023-8. PubMed ID: 19762725 [TBL] [Abstract][Full Text] [Related]
16. Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood. Tutwiler V; Litvinov RI; Lozhkin AP; Peshkova AD; Lebedeva T; Ataullakhanov FI; Spiller KL; Cines DB; Weisel JW Blood; 2016 Jan; 127(1):149-59. PubMed ID: 26603837 [TBL] [Abstract][Full Text] [Related]
17. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood. Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970 [TBL] [Abstract][Full Text] [Related]
18. Interspecies comparison of platelet aggregation, LIBS expression and clot retraction: observed differences in GPIIb-IIIa functional activity. Jennings LK; White MM; Mandrell TD Thromb Haemost; 1995 Dec; 74(6):1551-6. PubMed ID: 8772236 [TBL] [Abstract][Full Text] [Related]
19. Role of G protein signaling in the formation of the fibrin(ogen)-integrin αIIbβ3-actin cytoskeleton complex in platelets. Budnik I; Shenkman B; Savion N Platelets; 2016 Sep; 27(6):563-75. PubMed ID: 27026498 [TBL] [Abstract][Full Text] [Related]